-

05:21:31 PM

ENOV Stock News

ENOV - Enovis Corp

01/17/23 9:00 AM

NYSE : ENOV

Enovis Expands Foot & Ankle Portfolio’s DynaClip® Family by Introducing Procedure-Specific Staples

Today, Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced the launch of the

RHEA-AI

positive

01/05/23 3:10 PM

NYSE : ENOV

conferences

Enovis to Participate in the 41st Annual J.P. Morgan Healthcare Conference

Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will meet with investors at the 41 st Annual J.P. Morgan Healthcare Conference with a presentation scheduled for

RHEA-AI

neutral

12/01/22 9:00 AM

NYSE : ENOV

fda approval

Enovis Receives FDA Approval of Patient Specific Instrumentation for STAR® Ankle

Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology

RHEA-AI

very positive

11/17/22 8:00 AM

NYSE : ENOV

Enovis Introduces DynaNail Helix™ – a New Twist on Hindfoot Fusions

Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology company, announces the introduction of the

RHEA-AI

positive

11/10/22 10:30 AM

NYSE : ENOV

Enovis’ ARVIS® Awarded the AAHKS Industry Innovation Award at the 2022 American Academy of Hip and Knee Surgeons Annual Meeting

Today, Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced that the company’s ARVIS ® Augmented Reality Surgical Guidance System received the Industry Innovation Award at the this year’s American Academy of

RHEA-AI

very positive

11/02/22 6:00 AM

NYSE : ENOV

Enovis Announces Third Quarter 2022 Results

Grew sales to $384 million , including 7% organic growth over the prior year quarter, with double-digit growth performance across its Reconstructive segment Reported a net loss of $(1.22) per diluted share from continuing operations and increased its adjusted earnings per share 34% to $0.59

RHEA-AI

positive

10/28/22 3:57 PM

NYSE : ENOV

conferences

Enovis to Participate in Investor Conferences in November

Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that it will participate in two investor conferences in November. On Tuesday, November 8, Chris Hix, CFO, and Ben Berry, incoming CFO, will

RHEA-AI

neutral

10/13/22 9:30 AM

NYSE : ENOV

conferences

Enovis to Host Third Quarter 2022 Conference Call on November 2nd

Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its third quarter 2022 financial results on Wednesday, November 2, 2022

RHEA-AI

neutral

09/08/22 9:30 AM

NYSE : ENOV

Enovis to Showcase New 510(k) Cleared Foot & Ankle Products at the AOFAS Annual Meeting

Today, Enovis Corporation (NYSE: ENOV), an innovation-driven, medical technology company, announced it

RHEA-AI

neutral

08/25/22 4:01 PM

NYSE : ENOV

conferences

Enovis to Participate in Investor Conferences in September

Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences in September. 2022 Wells Fargo Healthcare Conference o n

RHEA-AI

neutral

ENOV Data

IndustryPump and Pumping Equipment Manufacturing
Websitewww.colfaxcorp.com
CeoMatthew Trerotola
Security nameEnovis Corp
Issue typecs
SectorManufacturing
Sic code3561
Employees15400
Address420 National Business Pkwy Fl 5
StateMaryland
CityAnnapolis Junction
Zip20701-1079
CountryUS
Phone13013239000

About Enovis Corp

Colfax Corporation is a leading diversified technology company that provides specialty medical technologies and fabrication technology products and services to customers around the world, principally under the DJO and ESAB brands. Colfax believes that its brands are among the most highly recognized in each of the markets that it serves. The Company uses its Colfax Business System ('CBS'), a comprehensive set of tools, processes and values, to create superior value for customers, shareholders and associates.